Цель компании ДжоинТекСэлл: вывести на рынок Систему miniSTEM, которая позволит сделать клеточные технологии более доступными как для врача, так и для пациента.

+7 495 668 3911

info@jointechcell.com
ул. Авиаконструктора Микояна, д. 12, г. Москва, Россия

Monday-Friday: 9AM - 6PM

Saturday-Sunday: closed

+7 495 668 3911

info@jointechcell.com

AVIAKONSTRUKTORA MIKOYANA ST., BLD. 12

Moscow, Russia

UNIQUE TECHNOLOGY

The technology is based on an invention of our American partners that was developed and put into production in Russia, including for its marketing all over the world.

CLINICAL USE

We cooperate with various biopharmaceutical companies and academic medical centers to conduct clinical studies with the purpose to demonstrate SVF efficacy for the therapy of a wide range of diseases.

INNOVATIVE APPROACH

MiniStem technology is a simple and innovative approach used in the cell medicine. It can be called “a pocket laboratory”. The use of this technology will enable regular application of cell therapy in many spheres of medicine.

JOINTECHCELL WAS FOUNDED IN 2012 WITH THE PURPOSE TO IMPLEMENT A NEW TECHNOLOGY – A CLOSED SYSTEM FOR OBTAINING STROMAL VASCULAR FRACTION FROM HUMAN ADIPOSE TISSUE IN RUSSIA.

JoinTechCell’s purpose: miniStem system will increase the availability of cell technologies both for the physician and the patient.

Today, the company is concentrated on the development of a new platform which purpose is to obtain patient’s own cells with regenerative potential directly in the operating room – “point of care”. Soon a new medical device – a separator and a centrifuge-shaker system intended to obtain a standardized product – stromal vascular fraction (SVF) from adipose tissue will be launched to the market. Moreover, a registration dossier has been submitted for an enzyme required to break down any tissue while extracting cells from it.

We’ve been working on it in close cooperation with the Federal State Budgetary Institution “Central Clinical Hospital with a Polyclinics” of the Administrative Department of the President of the Russian Federation and other research and medical institutions of Russia. The technology developed does not require the clinics to have GMP-licensed manufacture to obtain cell products and enables implementation of successful “point of care” and “same surgical procedure” concepts. In early 2018, the device is to be licensed in the Russian Federation in compliance with local legislative acts and regulations.

miniSTEM Comby

MiniSTEM Comby is an “all-in-one” workstation with a specially designed centrifuge with a thermocontrol system.

READ MORE
miniSTEM Separator

MiniStem Separator is a closed, sterile, tightly sealed, disposable device for cell fractionation, where all stages of lipoaspirate fermentation and washing are performed in accordance with a well-developed protocol.

READ MORE

Therapeutic areas of interest

ORTHOPEDICS
UROLOGY
Plastic surgery
Ophthalmology
PHLEBOLOGY
  • THERAUPETIC AREA

    orthopedics/травматология

    condition

    Osteoarthritis
    Ligament Rupture
    Abnormally Healing Wounds

    Clinical Trials Phase

  • THERAPEUTIC AREA

    UROLOGY

    condition

    STRESS URINARY INCONTINENCE
    BLADDER NECK OBSTRUCTION
    ERECTILE DYSFUNCTION
    URETHRAL STRICTURES

    Clinical Trials Phase

  • THERAPEUTIC AREA

    PLASTIC SURGERY

    condition

    BREAST RECONSTRUCTION

    Clinical Trials Phase

  • THERAPEUTIC AREA

    OPHTHALMOLOGY

    condition

    GLAUCOMA

    Clinical Trials Phase

  • THERAPEUTIC AREA

    PHLEBOLOGY

    condition

    CRITICAL LIMB ISCHEMIA

    Clinical Trials Phase

1

RU patent, 1 patent application, 1 PCT patent application

2016

September 2016 - 2nd National Congress on regenerative medicine, oral report

2016

November 2016 5th Congress ISPRES, oral report

2016

December 2016 - Congress IFATS, oral report

Partners